Invivyd, Inc. (IVVD) vs Q32 Bio Inc. (QTTB)

Invivyd, Inc. and Q32 Bio Inc. are both Biotechnology companies. Invivyd, Inc. and Q32 Bio Inc. are of similar size ($282.8M and $274.1M). Invivyd, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.9×. Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against −307.3%. Q32 Bio Inc. has the higher net margin (0.00% vs −183.9%) and the higher return on invested capital (0.00% vs −334.9%). Across the 15 metrics below, Q32 Bio Inc. leads on 13 and Invivyd, Inc. on 2.

Valuation

Metric IVVD QTTB Biotechnology median
P/E n/m 2.90 7.88
P/S 5.11 n/m 11.47
P/B 1.65 1.68 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.36 (12.07) 10.73
Earnings yield (35.48%) 34.44% (28.84%)
Free cash flow yield (36.80%) (7.23%) (23.03%)

Profitability

Metric IVVD QTTB Biotechnology median
Gross margin 92.23% 100.00% 65.16%
Operating margin (192.81%) 0.00% 0.00%
Net margin (183.90%) 0.00% 0.00%
Free cash flow margin (187.88%) 0.00% 0.00%
Return on equity (95.89%) 72.14% (57.72%)
Return on assets (69.69%) 37.13% (49.22%)
Return on invested capital (334.92%) 0.00% 0.00%

Growth

Metric IVVD QTTB Biotechnology median
Revenue growth (TTM) 26.30% (307.33%) 5.64%
EPS growth (last fiscal year) 79.02% 148.96% —
Revenue growth, 5-year CAGR — 100.32% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IVVD QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.87 20.30 4.73
Net debt to EBITDA 4.24 (2.21) 0.96

Dividend

Metric IVVD QTTB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IVVD QTTB Biotechnology median
Market cap 274.12m 282.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack